TargetMol

VX 759

Product Code:
 
TAR-T29149
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T29149-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29149-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29149-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
VX 759, a nonstructural protein 5B (NS5B) inhibitor, is used potentially for the treatment of HCV infection.
CAS:
478025-29-5
Formula:
C22H27NO3S
Molecular Weight:
385.52
Purity:
0.98
SMILES:
CC(C)N(C(=O)C1CCC(C)CC1)c1cc(sc1C(O)=O)-c1ccccc1

References

1. Snider TH, Wilhelm CM, Babin MC, Platoff GE Jr, Yeung DT. Assessing the therapeutic efficacy of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig. J Toxicol Sci. 2015 Dec;40(6):759-75. doi: 10.2131/jts.40.759. PubMed PMID: 26558457; PubMed Central PMCID: PMC4747113. 2. De Clercq E. Current race in the development of DAAs (direct-acting antivirals) against HCV. Biochem Pharmacol. 2014 Jun 15;89(4):441-52. doi: 10.1016/j.bcp.2014.04.005. PubMed PMID: 24735613. 3. Xin L, Lanz B, Lei H, Gruetter R. Assessment of metabolic fluxes in the mouse brain in vivo using 1H-[13C] NMR spectroscopy at 14.1 Tesla. J Cereb Blood Flow Metab. 2015 May;35(5):759-65. doi: 10.1038/jcbfm.2014.251. PubMed PMID: 25605294; PubMed Central PMCID: PMC4420852. 4. Godzik P, Komorowski M, Cielecka-Kuszyk J, Madali?ski K. [Inhibitors of hepatitis C virus--current standards and status of investigations]. Przegl Epidemiol. 2010;64(4):473-8. Polish. PubMed PMID: 21473060.